Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    1%
    Check dated 2025-10-05T09:34:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page shifts from detailed cancer histology terms to broader immunology-related topics and updates to a new revision (v3.1.0), removing several cancer-specific classifications (v3.0.2).
    Difference
    2%
    Check dated 2025-09-28T03:06:42.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Updated the page to Revision v3.0.2 from v3.0.1, and removed the old 'Back to Top' element.
    Difference
    0.1%
    Check dated 2025-09-13T16:47:28.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v3.0.1, indicating a recent revision. The previous version, v3.0.0, has been removed from the page.
    Difference
    0.1%
    Check dated 2025-09-06T14:10:05.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as specific medical terms related to ovarian cancer, while removing outdated location details and certain genetic resources.
    Difference
    4%
    Check dated 2025-08-30T11:07:31.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The web page has updated its content to reflect the addition of the CommonSpirit Cancer Center Mercy and the revision to version 2.16.12, while removing references to Southwest Oncology PC and the previous revision version 2.16.11.
    Difference
    0.4%
    Check dated 2025-08-16T04:16:03.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.